{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:01:45Z","timestamp":1790424105222,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess whether two cluster analysis-based axial SpA (axSpA) endotypes (A for purely axial; B for both axial and peripheral) are stable over time and are associated with different long-term disease outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>K-means cluster analysis was performed at each visit (until 5\u2009years) on 584 patients from the DESIR cohort, who completed all planned visits, and validated in 232 consecutive axSpA patients from the BeGiant cohort. Cluster stability overtime was assessed by kappa statistics. A generalized linear mixed-effect analysis was applied to compare outcomes between clusters. Classification and regression tree (CART) analysis was performed to determine a decision rule able to assign a given patient to a definite cluster at onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both endotypes remained remarkably stable over time. In the DESIR cohort, patients in cluster B showed higher disease activity, worse functional outcome and higher need for anti-rheumatic drugs than patients in cluster A. CART analysis yielded three main clinical features (arthritis, enthesitis and dactylitis) that accurately determined cluster assignment. These results could be replicated in the Be-GIANT cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cluster-based axSpA endotypes were reproducible in two different cohorts, stable over time and associated with different long-term outcome. The axSpA endotype with additional peripheral disease manifestations is associated with more severe disease and requires more intensive drug therapy<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>clinicaltrials.gov, https:\/\/clinicaltrials.gov, NCT01648907.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab873","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:29:47Z","timestamp":1638293387000},"page":"3289-3298","source":"Crossref","is-referenced-by-count":17,"title":["Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1449-959X","authenticated-orcid":false,"given":"F\u00e9licie","family":"Costantino","sequence":"first","affiliation":[{"name":"UVSQ, Inserm U1173, Infection et inflammation, Laboratory of Excellence INFLAMEX, Universit\u00e9 Paris-Saclay , Montigny-Le-Bretonneux"},{"name":"Rheumatology Department, AP-HP, Ambroise Par\u00e9 Hospital , Boulogne-Billancourt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aegerter","sequence":"additional","affiliation":[{"name":"UVSQ, Inserm U1018, CESP , , Montigny-Le-Bretonneux"},{"name":"Universit\u00e9 Paris-Saclay , , Montigny-Le-Bretonneux"},{"name":"GIRCI IdF\u2014UFR M\u00e9decine , , Boulogne-Billancourt, France"},{"name":"Paris-Ile-de-France-Ouest Universit\u00e9 , , Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3\u2014Rheumatology and Immunology"},{"name":"Deutsches Zentrum f\u00fcr Immuntherapie, Friedrich Alexander University Erlangen- Nuremberg and Universitatsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-8934","authenticated-orcid":false,"given":"Ann-Sophie","family":"De Craemer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Division of Rheumatology, Ghent University Hospital"},{"name":"Inflammation Research Center, VIB-UGent , Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1986","authenticated-orcid":false,"given":"Anna","family":"Molto","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Universit\u00e9 de Paris, Inserm U1153"},{"name":"Rheumatology Department, AP-HP, Cochin Hospital , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van den Bosch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Division of Rheumatology, Ghent University Hospital"},{"name":"Inflammation Research Center, VIB-UGent , Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Division of Rheumatology, Ghent University Hospital"},{"name":"Inflammation Research Center, VIB-UGent , Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Breban","sequence":"additional","affiliation":[{"name":"UVSQ, Inserm U1173, Infection et inflammation, Laboratory of Excellence INFLAMEX, Universit\u00e9 Paris-Saclay , Montigny-Le-Bretonneux"},{"name":"Rheumatology Department, AP-HP, Ambroise Par\u00e9 Hospital , Boulogne-Billancourt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Antonietta","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"UVSQ, Inserm U1173, Infection et inflammation, Laboratory of Excellence INFLAMEX, Universit\u00e9 Paris-Saclay , Montigny-Le-Bretonneux"},{"name":"Rheumatology Department, AP-HP, Ambroise Par\u00e9 Hospital , Boulogne-Billancourt"},{"name":"Rheumatology Unit, Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCSS , Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2022080317040244600_keab873-B1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.37829","article-title":"Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?","volume":"65","author":"Baeten","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022080317040244600_keab873-B2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/acr.21994","article-title":"Prevalence of axial spondyloarthritis in United States rheumatology practices: assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis","volume":"65","author":"Strand","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2022080317040244600_keab873-B4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.20990","article-title":"The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?","volume":"52","author":"Rudwaleit","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022080317040244600_keab873-B5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis","volume":"18","author":"de Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2022080317040244600_keab873-B7","first-page":"1883","article-title":"Predictive factors for the longterm outcome of spondyloarthropathies","volume":"21","author":"Amor","year":"1994","journal-title":"J Rheumatol"},{"key":"2022080317040244600_keab873-B8","first-page":"2054","article-title":"The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis","volume":"30","author":"Brophy","year":"2003","journal-title":"J Rheumatol"},{"key":"2022080317040244600_keab873-B9","doi-asserted-by":"crossref","first-page":"e000204","DOI":"10.1136\/rmdopen-2015-000204","article-title":"Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohort","volume":"2","author":"Lukas","year":"2016","journal-title":"RMD Open"},{"key":"2022080317040244600_keab873-B10","doi-asserted-by":"crossref","first-page":"e000802","DOI":"10.1136\/rmdopen-2018-000802","article-title":"Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis","volume":"5","author":"de Winter","year":"2019","journal-title":"RMD Open"},{"key":"2022080317040244600_keab873-B11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13075-019-1927-6","article-title":"Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort","volume":"21","author":"L\u00f3pez-Medina","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022080317040244600_keab873-B12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3899\/jrheum.181331","article-title":"Peripheral manifestations in spondyloarthritis and their impact: an ancillary analysis of the ASAS-COMOSPA study","volume":"47","author":"L\u00f3pez-Medina","year":"2020","journal-title":"J Rheumatol"},{"key":"2022080317040244600_keab873-B13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","article-title":"The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients","volume":"78","author":"Dougados","year":"2011","journal-title":"Joint Bone Spine"},{"key":"2022080317040244600_keab873-B14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/art.39628","article-title":"Two phenotypes are identified by cluster analysis in early inflammatory back pain suggestive of spondyloarthritis: results from the DESIR cohort","volume":"68","author":"Costantino","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022080317040244600_keab873-B15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B17","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2022080317040244600_keab873-B18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B19","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J. Rheumatol"},{"key":"2022080317040244600_keab873-B20","first-page":"946","article-title":"A modification of the health assessment questionnaire for the spondyloarthropathies","volume":"17","author":"Daltroy","year":"1990","journal-title":"J Rheumatol"},{"key":"2022080317040244600_keab873-B21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","article-title":"The Bath Ankylosing Spondylitis patient global score (BAS-G)","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2022080317040244600_keab873-B22","doi-asserted-by":"crossref","first-page":"2050312116671725","DOI":"10.1177\/2050312116671725","article-title":"SF-36 total score as a single measure of health-related quality of life: scoping review","volume":"4","author":"Lins","year":"2016","journal-title":"SAGE Open Med"},{"key":"2022080317040244600_keab873-B23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Softw"},{"key":"2022080317040244600_keab873-B25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2307\/2346830","article-title":"Algorithm AS 136: a K-means clustering algorithm","volume":"28","author":"Hartigan","year":"1979","journal-title":"Appl Stat"},{"key":"2022080317040244600_keab873-B26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.csda.2006.11.025","article-title":"Cluster-wise assessment of cluster stability","volume":"52","author":"Hennig","year":"2007","journal-title":"Comput Stat Data Anal"},{"key":"2022080317040244600_keab873-B27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"2022080317040244600_keab873-B28","author":"Kuhn","year":"2018"},{"key":"2022080317040244600_keab873-B29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/annrheumdis-2016-209785","article-title":"Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort","volume":"76","author":"Molto","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B30","doi-asserted-by":"crossref","first-page":"e000755","DOI":"10.1136\/rmdopen-2018-000755","article-title":"Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life","volume":"4","author":"Imkamp","year":"2018","journal-title":"RMD Open"},{"key":"2022080317040244600_keab873-B31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/annrheumdis-2019-216516","article-title":"What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022080317040244600_keab873-B32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.21070","article-title":"Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families","volume":"53","author":"Porcher","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022080317040244600_keab873-B33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10067-018-4112-4","article-title":"Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage","volume":"37","author":"L\u00f3pez-Medina","year":"2018","journal-title":"Clin. Rheumatol"},{"key":"2022080317040244600_keab873-B34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13075-018-1784-8","article-title":"Forsblad-d\u2019Elia H. Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex","volume":"20","author":"Law","year":"2018","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab873\/41725243\/keab873.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3289\/45226614\/keab873.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3289\/45226614\/keab873.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:06:12Z","timestamp":1659531972000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/8\/3289\/6448778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,12,3]]},"published-print":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab873","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2021,12,3]]}}}